The deadline for rheumatology teams to apply to the Aspiring to Excellence programme has now been extended to 18 September 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.
There are six rheumatology teams from across the UK currently involved in the programme who are progressing with projects aimed at improving the quality of care for patients with axial SpA (AS.) The teams recently met virtually to share their experiences of COVID-19 and the impact on their service and team members. Learning from the last few weeks will be incorporated into the programme and we are keen to keep driving forward with the second cohort of Aspiring to Excellence, so we welcome applications. All the application details can be found on the NASS website. For further information please contact: aspiringtoexcellence@nass.co.uk.